ARCHIVES

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

This article is from The Cancer Letter archive.

Vol. 15 No. 16 | April 21, 1989

Download PDF Visit The Full Archive

Related Articles

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

New “JNC” Popular Replacement For Old Journals

May 20, 1988

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013